,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
enhertu could transform #breastcancer treatment, landmark her2-low trial suggests. #asco22 #asco2022
The leading online provider of #CME, #CNE, #CE, and #CPE across 30+ medical specialties to support health professionals in improving patient care.